Afamitresgene autoleucel companion diagnostic - Agilent Technologies
Alternative Names: MAGE-A4 IHC 1F9 pharmDx; SK-032Latest Information Update: 14 Aug 2024
At a glance
- Originator Agilent Technologies
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Synovial sarcoma